Abstract
Introduction
MMs were classified on the basis of the WHO classification of pleural tumors [31] . 
Information on risk factors of melanoma probands

146
The role of UV exposure is well known in the development of melanoma. People with pale 147 skin are at higher risk for this tumor. Dysplastic and/or melanocytic nevi are considered 148 premalignant lesions in melanoma carcinogenesis [34] . Thus, the professional or chronic UV 149 exposure, the occurrence of dysplastic and/or melanocytic nevi and Fitzpatrick skin phototype were 150 evaluated in melanoma probands. The 17 exons, intron-exon boundaries and promoter region (~1000bp upstream of the ATG) BAP1 was considered positive when a weak-to-strong nuclear positivity was shown. The specificity 
198
To detect the p16 protein, every tumor was given a score according to the intensity of the nuclear or 199 cytoplasmic staining (no staining; weak staining; moderate staining; strong staining). A stained 200 slide with a high-degree intraepithelial lesion of the uterine cervix was used as a positive control. Provean, Polyphen-2, Mutation assessor, Condel, Phyre2), segregation analysis.
209
Since a change in a coding sequence may activate a cryptic splice site, we have also evaluated 210 splice site prediction using seven different tools (Human Splicing Finder, MaxEnt, BDGP,
211
NetGene2, GeneScan, FGENESH 2.6, FSPLICE 1.0).
212
As controls for the prediction programs, we used the five most frequent missense variants in ExAC,
213
(these variants are expected to be silent changes, since they are commonly found in normal 214 individuals).
215
We considered LOH, IHC or splice site prediction as the most important parameters. If LOH and 216 IHC data were not available, we considered as pathogenic a missense variant that has a disease 217 causing potential for at least 5/7 tools.
218
Segregation should be evaluated taking into consideration that frequent cancers may also occur as 219 phenocopies, i.e. patient with cancer but without the mutation identified in other affected family 220 members. Phenocopies are events not so rare in inherited cancer predisposition syndromes. 
Results
231
Risk factors
232
Information on asbestos exposure was available for 10 out of 12 mesothelioma probands
233
(Supplementary Table I ). All of them showed asbestos exposure, in agreement with literature [32] .
234
Possible occupational exposure was reported for four probands, para-occupational or household 235 exposure forfive patients and both possible occupational and household exposure for one proband.
236
One out of 28 melanoma probands showed professional or chronic UV exposure.
237
Information regarding Fitzpatrick skin phototype was available for 16 out of 28 probands: one had 238 phototype I, 10 had phototype II and 5 had phototype III. Information about dysplastic and/or 239 melanocytic nevi was available for 13 patients. Whereas one proband showed dysplastic nevi, 13
240
showed melanocytic nevi (7 probands <10, 2 probands 10-50, 4 probands >50). In total, 17 out of 241 28 probands showed at least well-documented risk factor (Supplementary Table I 
Mutation analysis
246
Among the 40 probands with a family history of cancer we identified four BAP1 germline 247 variants and a recurrent pathogenic germline mutation in CDKN2A in three and one index cases, 248 respectively (Table I) .
249
Two BAP1 and one CDKN2A germline variants were found in families with both 250 mesothelioma and melanoma. Two other BAP1 germline variants were identified in a patient with 251 multiple cutaneous amelanotic melanomas (Table I) .
252
The proband of family ID5 carried a heterozygous nonsense mutation in BAP1 gene Table I ). The mutation was transmitted to the proband's 262 healthy daughter (III-2 PB, Figure 1 A2 ) while the proband's brother died because of a basal cell 263 carcinoma, but no sample was available for segregation analysis.
264
The proband of melanoma family ID16 developed two cutaneous amelanotic melanomas and paternal uncle was not due to the aforementioned BAP1 germline variants.
274
The missense variant appeared in heterozygous state also in the two melanomas from the proband
275
(IV-1 CM_1, IV-1 CM_2, Figure 1 B2 ).
276
Microsatellites analysis, performed on genomic and tumor DNAs, showed a decreased amount of 
281
The presence of BAP1 protein was ascertained by IHC on FFPE pertaining to the two different 282 melanomas from the proband (IV-1 CM_1, IV-1 CM_2, Figure 1 B4 
295
We have also performed a prediction of the three dimensional structure of the variant protein 296 according to Protein Homology/analogy Recognition Engine v.2 (Phyre2). The mutant hydrophobic
297
Ala567 is predicted to be buried within the globular portion of the protein and the relevant domains 298 of the BAP1 protein seem to assume a different position (Supplementary Figure 2) .
299
In conclusion, a functional assay is strongly needed to assess the pathogenicity of missense variants 300 including p.Asp567Ala.
301
The duplication in the promoter was predicted to remove a MAZ (MYC-Associated Zinc Finger 302 Protein) binding site by PROMO (TRANSFAC), but has no effect on transcription factor binding considering that the protein is expressed, our data overall suggest that the duplication is a likely 306 neutral variant.
307
The proband of family ID4 showed a heterozygote 19bp duplication (c.- Probands from the other families were analyzed using the same strategy, but no other 316 germline variant was found in BAP1 gene.
317
Conversely, a recurrent pathogenic germline mutation (c.301G>T, p.Gly101Trp, exon 2) in 318 CDKN2A was found in the family ID3 showing both melanoma and mesothelioma. The CDKN2A 319 germline mutation was carried by the proband affected by cutaneous melanoma and by her mother 320 affected by both cutaneous melanoma and mesothelioma (III-3 PB, II-3 FFPE non-tumor tissue respectively, Figure 1 C2 ). This mutation was found in heterozygosity with the wild type sequence 322 also in mesothelioma from the proband's mother (II-3 MM, Figure 1 C2 ).
323
Mesothelioma cells showed nuclear staining at IHC with anti-p16 antibody (II-3 MM, Figure 1 C3 ) 324 although the intensity of nuclear expression was slightly lower in less differentiated tumor cells.
325
MLPA analysis was performed on germline DNA from all the probands, but no copy 326 number variations has been identified.
327
The probands from the other families under study were sequenced for the most common 328 melanoma predisposition genes (CDKN2A, CDK4 exon 2, TERT promoter, MITF exon 9, POT1 329 exon 10), but no additional germline variant was found. Details of the results for each proband are 330 reported in Table 1 Asbestos exposure at work of the proband's mother was assessed as 'low exposure', a 384 category including all occupational exposures occurring outside industries were asbestos was 385 directly used as a raw material.
386
Patients with BAP1 mutations seem to develop mesothelioma even after a low asbestos 387 exposure [1] . Our finding suggests that the CDKN2A p.Gly101Trp behaves as BAP1 mutations: the 388 mutation carrier is at high risk for tumors and the type of carcinogen exposure is important for the 389 cancer type that is developed. In conclusion, our study suggests for the first time that also CDKN2A 390 may predispose to MM.
391
Although the coincidence of two rare tumors in a single patient promptly suggests a 392 common origin, we cannot exclude the independent occurrence of a malignant mesothelioma in a 393 patient otherwise predisposed to melanoma. Indeed, we failed to identify additional CDKN2A 394 germline mutations in our series but the same is true for BAP1 whose mutations are very rare and do 395 not explain most familial clustering of tumors investigated in this work, as well as cases or families 396 with both melanoma and renal cell cancer.
397
Both BAP1 and CDKN2A genes are found somatically deleted or mutated in MM tissues
398
[51]. This study further supports that loss of either BAP1 or CDKN2A is an important step in both 399 melanoma and MM carcinogenesis and individuals that carry a germline mutation in either of these 400 two genes might have an increased risk for both tumors. [1] . The authors considered this variant as possibly damaging, using a single prediction tool (Polyphen). We have integrated 695 this in silico analysis using six prediction tools, i.e. Mut taster, SIFT, Provean, Mut assessor, Condel, and Phyre2. To assess a possible aberrant splicing we used Human Splicing
696
Finder, MaxEnt, BDGP, NetGene2, GeneScan, FGENESH 2.6 and FSPLICE 1.0. Four out of seven disease-causing prediction tools reported the p.Thr77Ala variant as neutral.
697
No data are reported for LOH, IHC and segregation analysis. Moreover, none of the 7 splice-site prediction tools has shown the creation of alternative splice sites for this variant.
698
Thus, we concluded that the p.Thr77Ala variant should be considered as a VUS and the patient was considered eligible for mutation analysis in other genes.
700
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Supplementary Figure 1-BAP1 germline duplications
The proband is denoted by a black arrow. A plus symbol indicates individuals with germline variant. A grey arrow denotes the mutation in the electropherogram. PB (peripheral blood).
A. Family ID16. Pedigree is reported in Figure 1B . A1. Electropherogram: a new germline 5bp duplication (c.-594dupCCCGT) in the BAP1 promoter region was found in the proband (IV-1 PB), in a sister (IV-2 PB), in her mother (III-5 PB) and in her maternal aunt (III-6 PB). This duplication is in cis with the p.Asp567Ala missense variant.
B. Family ID4. B1. Pedigree: the proband (II-1) had cutaneous melanoma and breast cancer, the brother (II-2) had papillary renal cell carcinoma type 2, the father (I-1) died for mesothelioma and the mother (I-2) had breast cancer. B2. Electropherogram: a new germline 19bp duplication (c.-247dupCCTTCGCCCCCGTCCCTCC) in the BAP1 promoter region was found in the proband (II-1 PB). No specimens from relatives were available for segregation analysis.
Supplementary Figure 2 -Predicted structure of BAP1 protein
Predicted structure of BAP1 protein according to Protein Homology/analogY Recognition Engine v 2.0 (Phyre2). The yellow arrows indicate the position of D567 (a) or the mutant A567 (b). The wild type negative charged D567 seems to localize at the interface with the ubiquitin carboxyterminal hydrolase domain (residues 1-240) depicted in dark to light blue with the catalytic sites Q85, C91, H169 and D184 shown in white. Known domains are indicated with different colours according to their position: HCFC1 binding motif in green (residues 363-366), the long alpha helix of the BRCA1 binding domain in orange (residues 629-659/669) and the Nuclear Localization Signal (NLS, residues 717-722) in red. The mutant hydrophobic A567 is predicted buried within the globular portion of the protein and the relevant domains of the BAP1 protein seem to assume a different position. 
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